TITLE

Statins may decrease cancer risk

AUTHOR(S)
Blumenthal, Roger S.
PUB. DATE
March 2008
SOURCE
Hem/Onc Today;3/10/2008, Vol. 9 Issue 4, p46
SOURCE TYPE
Newspaper
DOC. TYPE
Article
ABSTRACT
The article discusses research which revealed that statin use may decrease the risk for developing cancer. It references a study published in a 2008 issue of the "Journal of the National Cancer Institute." Statin use was analyzed by researchers for cancer prevention among patients enrolled in the Veterans Affairs New England Healthcare System between January 1997 and December 2005.
ACCESSION #
31672229

 

Related Articles

  • Statin-related news stories influence adherence.  // Reactions Weekly;12/19/2015, Vol. 1582 Issue 1, p12 

    The article discusses research published in the December 2, 2015 issue of "European Heart Journal" that shows the association of negative news stories about HMG-CoA reductase inhibitors (statins) with early discontinuation of statin therapy.

  • Large study finds commonly used statins safe.  // Cardiology Today;Aug2013, Vol. 16 Issue 8, p1 

    The article discusses a study published in "Cardiovascular Quality and Outcomes" which concluded that statins are associated with low risk adverse effects.

  • Marked differences in frequencies of statin therapy relevant SLCO1B1 variants and haplotypes between Roma and Hungarian populations. Nagy, Agnes; Sipeky, Csilla; Szalai, Renata; Melegh, Bela Imre; Matyas, Petra; Ganczer, Alma; Toth, Kalman; Melegh, Bela // BMC Genetics;9/3/2015, Vol. 16 Issue 1, p1 

    Background: SLCO1B1 polymorphisms are relevant in statin pharmacokinetics. Aim of this study was to investigate the genetic variability and haplotype profile of SLCO1B1 polymorphisms in Roma and Hungarian populations. Genotypes of 470 Roma and 442 Hungarian subjects for c.388A > G, c.521T > C...

  • Marked differences in frequencies of statin therapy relevant SLCO1B1 variants and haplotypes between Roma and Hungarian populations. Nagy, Agnes; Sipeky, Csilla; Szalai, Renata; Melegh, Bela Imre; Matyas, Petra; Ganczer, Alma; Toth, Kalman; Melegh, Bela // BMC Genetics;9/5/2015, Vol. 16 Issue 1, p1 

    Background: SLCO1B1 polymorphisms are relevant in statin pharmacokinetics. Aim of this study was to investigate the genetic variability and haplotype profile of SLCO1B1 polymorphisms in Roma and Hungarian populations. Genotypes of 470 Roma and 442 Hungarian subjects for c.388A>G, c.521T>C and...

  • Better cholesterol control with mail-order statins.  // PharmacoEconomics & Outcomes News;8/6/2011, Issue 634, p6 

    The article deals with research from Kaiser Permanente Northern California which reveals that statin prescriptions obtained through a mail-order pharmacy lead to better cholesterol control in the first 3-15 months of therapy compared to prescriptions obtained only through a local pharmacy.

  • Red Yeast Rice--Not a Good Alternative to Statins.  // HealthFacts;Jul2009, Vol. 34 Issue 7, p6 

    The article features the study conducted on the efficacy of red yeast rice as an alternative to statins in the U.S. Researchers did the trial on 62 statin-intolerant participants who are randomly assigned to take either the red yeast rice supplements or the placebo twice a day for six months....

  • Management of statin intolerance. Raju, Soma B.; Varghese, Kiron; Madhu, K. // Indian Journal of Endocrinology & Metabolism;Nov/Dec2013, Vol. 17 Issue 6, p977 

    Statins are the revolutionary drugs in the cardiovascular pharmacotherapy. But they also possess several adverse effects like myopathy with elevation of hepatic transaminases (>3 times the upper limit of normal) or creatine kinase (>10 times the upper limit of normal) and some rare side-effects,...

  • Diabetogenic Effect of Statins: A Double-Edged Sword? Ji Sung Yoon; Hyoung Woo Lee // Diabetes & Metabolism Journal;Dec2013, Vol. 37 Issue 6, p415 

    Statins are widely prescribed cholesterol-lowering agents, which have been demonstrated to significantly reduce cardiovascular morbidity and mortality. However, recent trials have reported that statins cause worsening of hyperglycemia and increase the risk of new-onset diabetes. The association...

  • Effect of Statins on Venous Thromboembolic Events: A Meta-analysis of Published and Unpublished Evidence from Randomised Controlled Trials. Rahimi, Kazem; Bhala, Neeraj; Kamphuisen, Pieter; Emberson, Jonathan; Biere-Rafi, Sara; Krane, Vera; Robertson, Michele; Wikstrand, John; McMurray, John // PLoS Clinical Trials;Sep2012, Vol. 7 Issue 9, p1 

    A systematic review and meta-analysis conducted by Kazem Rahimi and colleagues re-evaluates the hypothesis, generated in previous studies, that statins may reduce the risk of venous thromboembolic events. Their meta-analysis does not support the previous findings.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics